These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1990530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synergistic interactions between anti-interleukin-2 receptor (IL-2R) MAb and CyA in sensitized rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Sablinski T, Hancock WW, Mix CT, Tilney NL.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):285-6. PubMed ID: 1990533
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Microchimerism and graft acceptance: IV. Cardiac allograft acceptance following anti-adhesion molecule antibody therapy.
    Suzuki H, Hara MH, Miyahara T, Tanigawa M, Matsuzaki Y, Onitsuka T, Shibata K, Koga Y, Yamashita A, Miyamoto M, Suzuki S, Amemiya H, Iwaya M, Miyasaka M, Kimura H.
    Transplant Proc; 1996 Aug; 28(4):2058-60. PubMed ID: 8769155
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Specific unresponsiveness in rats with prolonged allograft survival is dependent upon the graft and suppressor T cells.
    Hall BM, Gurley K, Dorsch SE.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):495-6. PubMed ID: 2978915
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH, Hancock WW, Colby AJ, Padberg W, Diamantstein T, Kupiec-Weglinski JW, Tilney NL.
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 13. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients.
    Onodera K, Lehmann M, Volk HD, Sayegh MH, Kupiec-Weglinski JW.
    Transplant Proc; 1997 May 01; 29(3):1907-8. PubMed ID: 9142316
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin 2 receptor in rat allograft rejection.
    Bouchot O, Anegon I, Romaniuk A, Jacques Y, Soulillou JP.
    Transplant Proc; 1990 Aug 01; 22(4):1995-7. PubMed ID: 2202134
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.